Skip to content Skip to footer

Best Ways to Fix Peyronie’s Disease: Comprehensive Treatment Options and Management in Canada

Peyronie’s disease affects a significant number of men, leading to painful curvature, erectile dysfunction, and emotional distress. This guide defines key symptoms and causes, then maps an evidence-based roadmap through non-surgical therapies (oral drugs, injections, mechanical devices, shockwave), surgical interventions (plication, grafting, implants), and Health Canada–approved options like Xiaflex. You’ll learn how specialists diagnose and stage the condition, tailor treatment to acute vs. chronic phases, integrate lifestyle and psychological support, explore emerging regenerative approaches, and measure success rates. By following this comprehensive overview, men and their partners can navigate the path from early intervention to long-term restoration of sexual function and quality of life.

What Are the Symptoms and Causes of Peyronie’s Disease?

Peyronie’s disease is a connective tissue disorder characterized by fibrous plaque formation in the tunica albuginea. This abnormal scarring creates curvature, pain, and sometimes shortening during erection. Early recognition of symptoms and understanding underlying causes enables timely management and maximizes the chance of non-surgical correction.

What Are the Common Symptoms of Peyronie’s Disease?

Men with early Peyronie’s disease typically report:
  • Penile curvature during erection, which may bend upward, downward, or to one side
  • Penile pain, often described as sharp or burning, especially in the acute inflammatory phase
  • Erectile dysfunction, ranging from mild rigidity issues to inability to maintain erection
  • Palpable lumps or plaque on the shaft, felt as firm nodules under the skin
  • Shortening or narrowing of penile length in severe cases
These core signs not only impair sexual activity but can trigger anxiety and avoidance, underscoring the need for prompt evaluation.

What Causes Peyronie’s Disease?

Peyronie’s disease arises when micro-trauma to the erect penis triggers aberrant wound healing and collagen overproduction. Contributing factors include:
  • Penile trauma from vigorous intercourse or accidents
  • Genetic predisposition linked to Dupuytren’s contracture and other fibrotic disorders
  • Connective tissue disorders that amplify fibrotic activity
  • Autoimmune responses driving chronic inflammation and scar formation
  • Age-related changes in penile elasticity and repair mechanisms
Understanding these triggers helps urologists personalize prevention and early-phase therapies to reduce plaque progression.

How Does Peyronie’s Disease Progress Through Acute and Chronic Phases?

In the acute phase (up to 12–18 months), inflammation dominates. Pain and evolving curvature occur as plaque forms and matures. Interventions in this stage can slow or reverse curvature. Once plaque stabilizes and pain subsides, the chronic phase begins. At this point, curvature is fixed, and non-surgical measures yield diminishing returns unless combined with mechanical traction or surgery. Accurate staging directs whether to prioritize anti-inflammatory drugs or plan definitive correction.

What Are the Risk Factors and Prevention Strategies for Peyronie’s Disease?

Penile curvature risk rises with age and comorbidities. The following table links risk factors to actionable prevention:
Risk Factor Prevention Strategy
Age over 40 Early screening and pelvic floor exercises
Diabetes or metabolic syndrome Blood sugar control and vascular health management
Smoking Smoking cessation programs to improve tissue oxygenation
Prostate surgery history Post-op penile rehabilitation with traction and pharmacotherapy
Connective tissue conditions Routine monitoring and antioxidant supplementation
Proactive measures can reduce incidence and limit plaque size in susceptible men, preserving penile function and reducing future treatment intensity.

What Non-Surgical Treatments Are Available for Peyronie’s Disease?

Non-surgical therapies aim to reduce plaque size, improve curvature, and relieve pain without incisions. They are most effective in the acute phase or for mild-to-moderate deformity, preserving length and function.

How Effective Are Oral Medications for Peyronie’s Disease?

Oral agents work by modulating fibrosis and inflammation. Early administration can slow plaque formation and lessen curvature progression. Key options include:
Medication Mechanism Benefit
Pentoxifylline Improves microcirculation and inhibits TGF-β Reduces plaque density and curvature by up to 20 percent
Vitamin E Antioxidant scavenging of free radicals Modest pain relief and plaque stabilization
Colchicine Anti-inflammatory reducing fibroblast activity May decrease acute-phase pain and plaque size
PDE-5 inhibitors Enhances blood flow and reduces oxidative stress Supports erections and may attenuate fibrosis
Oral therapy protocols typically span 6–12 months. While benefits vary, combining agents can enhance outcomes and delay the need for invasive procedures.

What Are the Benefits and Protocols of Injectable Therapies?

Injectable agents deliver anti-fibrotic or enzyme treatments directly into the plaque to break down scar tissue:
  • Collagenase Clostridium Histolyticum (Xiaflex) breaks down collagen and remodels plaque, improving curvature by 30–40 percent over four cycles in Health Canada–approved protocols.
  • Verapamil injections disrupt collagen synthesis and reduce pain with weekly treatments over 8–12 weeks.
  • Interferon-α2b inhibits fibroblast proliferation and softens plaque in 6–12 sessions.
  • Platelet-Rich Plasma (PRP) combined with hyaluronic acid promotes regenerative signaling, showing promising curvature reduction and erectile function support in emerging clinics.
These therapies require ultrasound guidance and a treatment plan overseen by a urologist to optimize safety and efficacy.

How Do Mechanical Therapies Like Penile Traction Devices Work?

Mechanical stretching remodels scar tissue and can gradually improve curvature and length. A typical protocol involves:
  • Daily use of a traction device for 2–6 hours, applying 0.5–2 kg of tension
  • Incremental tension increases to stimulate collagen realignment
  • Concurrent monitoring by the treating specialist
Penile traction devices have demonstrated up to 15 percent curvature reduction in six months and can complement injectable or oral therapies.

What Is Shockwave Therapy and How Does It Help Peyronie’s Disease?

Low-intensity extracorporeal shockwave therapy (Li-ESWT) uses acoustic pulses to:
  • Promote neovascularization and improve blood flow
  • Disrupt plaque microarchitecture to soften scar tissue
  • Alleviate pain through nociceptor modulation
Clinical series report pain relief in 70 percent of men and mild curvature improvement. Li-ESWT is an option in acute or early chronic phases and integrates well with traction regimens.

When Should You Consult a Urologist for Non-Surgical Treatment?

  • Curvature exceeds 10 degrees or is worsening
  • Pain persists through two to three months
  • Erectile function declines despite oral therapy
  • Planning for combined mechanical or injectable approaches
A personalized plan accounting for disease stage, plaque characteristics, and erectile health maximizes non-surgical success and delays or avoids surgery.

What Surgical Options Exist for Treating Peyronie’s Disease in Canada?

When curvature is severe (>60 degrees), stable in the chronic phase, or accompanied by refractory erectile dysfunction, surgical correction offers definitive outcomes. Canadian centers provide expertise in three main procedures.

How Does Plication Surgery Correct Penile Curvature?

Plication, often via the Nesbit or 16-dot technique, involves shortening the longer side of the tunica albuginea opposite the plaque. This straightens the shaft by up to 90 percent while preserving erectile function. Recovery typically requires a two-week abstinence period, and length loss averages 1–2 cm.

What Is Grafting Surgery and When Is It Recommended?

Grafting removes or incises plaque tissue and covers the defect with a patch of venous or synthetic graft. Recommended for:
  • Curvatures >60 degrees with adequate penile length
  • Complex deformities such as hourglass narrowing
  • Strong patient preference for length preservation
Grafting can restore up to 3 cm of length but carries a higher risk of post-op erectile dysfunction, requiring thorough candidacy evaluation.

How Do Penile Implants Address Peyronie’s Disease and Erectile Dysfunction?

Inflatable or malleable penile prostheses replace spongy tissue to achieve rigidity while simultaneously correcting curvature. Ideal candidates have significant ED unresponsive to medication. Implants deliver 90 percent satisfaction rates and immediate straightening but require device management and carry surgical risks.

When Is Surgery the Best Choice for Peyronie’s Disease?

  • Stable curvature in the chronic phase with no pain
  • Severe deformity (>60 degrees) hindering penetrative sex
  • Persistent erectile dysfunction refractory to non-surgical therapies
  • Patient desire for immediate and definitive correction

How Does Xiaflex Work for Peyronie’s Disease Treatment in Canada?

Xiaflex is the only Health Canada–approved intralesional enzyme for Peyronie’s disease.

Xiaflex Approval in Canada

Health Canada approved Xiaflex (collagenase clostridium histolyticum) in January 2018 for the treatment of Peyronie’s disease in adult men with a palpable plaque and curvature deformity of at least 30 degrees. This approval marked a significant advancement in non-surgical treatment options.

What Is Collagenase Clostridium Histolyticum (Xiaflex)?

Xiaflex contains purified collagenase enzymes that specifically cleave collagen types I and III within plaque. By fragmenting fibrous scar tissue, Xiaflex softens the plaque and facilitates manual modeling to reduce curvature.

Who Is Eligible for Xiaflex Treatment?

Candidates must have:
  • Ventral or dorsal curvature between 30 and 90 degrees
  • Stable disease for at least three months
  • Palpable plaque accessible to injection
  • Adequate erectile function to perform modeling sessions
Contraindications include severe calcification and uncorrected bleeding disorders.

What Are the Expected Results and Side Effects of Xiaflex?

Over four treatment cycles, men achieve a mean curvature reduction of 30–40 percent. Reported side effects are generally mild and include local swelling, bruising, and transient penile pain. Rare complications like corporal rupture are mitigated by trained injection and modeling protocols.

How Is Xiaflex Accessed and Approved in Canada?

Health Canada granted Xiaflex prescription status in 2015. Access requires referral to a certified urologist or sexual medicine specialist. Private insurance often covers the drug and associated visits, while some clinics offer financing for out-of-pocket patients.

How Can Patients Manage Peyronie’s Disease Symptoms and Improve Quality of Life?

Beyond physical correction, addressing emotional well-being and lifestyle factors restores intimacy and confidence. A holistic approach combines medical care with behavioral strategies.

What Are the Psychological Impacts of Peyronie’s Disease?

Curvature and dysfunction often trigger stress, depression, and avoidance of sexual intimacy. Partner communication breakdown and low self-esteem are common. Integrating mental health support counseling, cognitive behavioral therapy, or support groups reduces anxiety and fosters shared coping strategies.

What Lifestyle Adjustments Support Peyronie’s Disease Management?

Men can adopt measures that optimize tissue health and vascular function:
  • Balanced diet rich in antioxidants to counteract fibrosis
  • Regular cardiovascular exercise to improve pelvic blood flow
  • Smoking cessation to enhance microvascular repair
  • Stress management techniques such as mindfulness or yoga
These habits complement medical therapies and support long-term penile health.

How Can Pain and Erectile Dysfunction Be Managed Alongside Peyronie’s Disease?

Combining strategies yields superior relief:
  • Oral analgesics and anti-inflammatories during acute pain
  • PDE-5 inhibitors for erections and antifibrotic effects
  • Topical numbing creams before intercourse
  • Vacuum erection devices to promote blood inflow and tissue remodeling
Coordinating these modalities under urologist supervision maximizes comfort and function.

Where Can Patients Find Support Groups and Resources in Canada?

Canadian men can turn to:
  • Canadian Urological Association patient information portal
  • Local men’s health clinics offering group sessions
  • Online forums moderated by healthcare professionals
  • Mental health charities providing relationship workshops
Connecting with peers and specialists reduces isolation and informs treatment choices.

What Are the Latest Advances and Emerging Therapies for Peyronie’s Disease?

Research into regenerative medicine and molecular pathways is expanding non-surgical horizons. Several novel approaches show promise but await larger trials and regulatory approval.

What Is the Role of Platelet-Rich Plasma (PRP) and Hyaluronic Acid Injections?

PRP concentrates growth factors that stimulate tissue repair, while hyaluronic acid provides anti-inflammatory cushioning. Early studies report curvature reduction of 10–15 percent and improved erectile parameters. These off-label treatments are available in select Canadian clinics under research protocols.

How Is Genetic and Molecular Research Shaping Future Treatments?

Investigations into TGF-β1 signaling and collagen type I gene variants are identifying drug targets to prevent plaque formation. Gene therapy and small-molecule inhibitors could one day halt fibrosis at the molecular level, shifting care from reactive to preventative.

What Are the Limitations and Current Status of Emerging Therapies in Canada?

Most regenerative approaches lack large-scale, randomized data. Health Canada has not yet approved PRP or stem cell treatments for Peyronie’s disease, so cost and access are restricted to clinical trials or specialized centers. Patients should weigh experimental benefits against expense and uncertain outcomes.

How Can Patients Stay Informed About New Treatment Options?

Men can monitor progress through:
  • ClinicalTrials.gov listings for Canadian studies
  • Peer-reviewed journals such as European Urology and Journal of Urology
  • Professional conferences like the Canadian Urological Association Annual Meeting
  • Trusted medical websites maintained by academic hospitals
Staying engaged ensures timely access to cutting-edge therapies as they become available.

How Is Peyronie’s Disease Diagnosed and Evaluated by Specialists?

Accurate diagnosis and staging are the foundation for targeted treatment selection. Urologists employ a combination of clinical and imaging tools to characterize the condition.

What Diagnostic Tests Are Used for Peyronie’s Disease?

Evaluation typically includes:
  • Physical examination with palpation of plaque and measurement of curvature
  • Penile duplex ultrasound to assess plaque size, calcification, and blood flow
  • International Index of Erectile Function (IIEF) questionnaire for baseline erectile function
  • Photographic documentation of erect penis for objective curvature analysis
These tests quantify severity and guide therapy intensity.

What Is the Role of the Urologist in Diagnosis and Treatment?

As penile specialists, urologists:
  • Confirm the diagnosis and differentiate from mimickers
  • Stage disease into acute or chronic phases
  • Discuss non-surgical vs. surgical options personalized to patient goals
  • Administer injections and oversee mechanical therapy protocols
  • Perform corrective surgery when indicated
Their expertise ensures safe procedures and optimized outcomes.

How Are Disease Severity and Erectile Dysfunction Assessed?

Severity assessment combines:
  • Angle of curvature measured with protractor or imaging
  • Plaque characteristics (size, calcification) via ultrasound
  • Erectile quality graded by IIEF scores and nocturnal tumescence tests
By correlating curvature degree with erectile status, clinicians select the most effective interventions.

How Does Diagnosis Influence Treatment Decisions?

Acute-phase, mild curvature favors non-surgical therapy and monitoring. Stable, severe deformity directs toward surgical correction or Xiaflex injections if eligible. Erectile dysfunction assessment further refines choices: men with both ED and curvature may benefit most from penile implants. Clear staging and assessment ensure each patient follows a tailored care pathway.

What Are the Success Rates and Outcomes of Peyronie’s Disease Treatments?

Evaluating real-world outcomes helps set realistic expectations and guide informed decision-making. Success is measured by curvature reduction, erectile improvement, and patient satisfaction.

How Effective Are Non-Surgical Treatments in Reducing Curvature?

  • Xiaflex yields 30–40 percent curvature reduction in 61 percent of men
  • Traction therapy achieves up to 15 percent straightening over six months
  • Verapamil injections reduce plaque size in 20–30 percent of cases
  • Shockwave therapy provides mild curvature improvement but excellent pain relief
Combining therapies often enhances overall efficacy and extends non-surgical windows.

What Are the Long-Term Results of Surgical Interventions?

  • Plication produces 90 percent straightening with less than 5 percent ED risk
  • Grafting restores length in 70 percent of men but carries 10–15 percent ED risk
  • Implants resolve curvature and ED in over 90 percent of recipients
Long-term satisfaction rates exceed 80 percent when expectations are aligned pre-operatively. Peyronie’s disease demands a personalized, phased approach from anti-fibrotic drugs and traction devices in the early stage to enzyme injections or definitive surgery in chronic cases. Health Canada–approved Xiaflex injections, combined with mechanical therapy, offer a robust non-surgical pathway, while plication, grafting, and implants deliver high rates of curvature correction when indicated. By partnering with a skilled urologist, adopting supportive lifestyle measures, and engaging mental health resources, men can regain function, confidence, and quality of life across every phase of Peyronie’s disease management.
Dr. Woo Kim in medical scrubs standing confidently in front of the Trinity Wellness logo, emphasizing personalized men's health care and wellness strategies.

Dr. Woo Kim, leads the Wellness Programs at Trinity Wellness in Midtown Toronto, bringing over two decades of chiropractic experience to his patients. A University of Toronto graduate, Dr. Kim earned his Doctor of Chiropractic from the Southern California University of Health Sciences in 2002, followed by a preceptorship in Pasadena, where he worked alongside an orthopedic surgeon in shoulder and knee rehabilitation. Returning to the GTA in 2003, he opened multiple clinics dedicated to chronic pain management and rehabilitation after traumatic injuries. Over the years, Dr. Kim developed his unique philosophy of Age Wellness an approach that recognizes each decade of life comes with distinct challenges and needs. From tendonitis in busy parents to pelvic floor and degenerative issues later in life, he tailors care to match where patients are in their journey. Now at 56, Dr. Kim’s mission is simple yet powerful: help people age well by blending innovative techniques and technology to restore function, ease discomfort, and support long-term vitality.